TABLE 3

Multivariate Analysis of Recurrence-Free and Overall Survival

Recurrence-free survivalOverall survival
VariableHazard ratio95% CIPHazard ratio95% CIP
RCB index0.924
 RCB-0Reference
 RCB-10.000.000.981
 RCB-21.620.41–6.420.490
 RCB-31.490.33–6.640.605
Clinical T stage0.265
 IReference
 II0.560.05–6.530.645
 III0.620.04–9.870.735
 IV2.820.18–44.200.461
Clinical N stage0.0150.05
 IReferenceReference
 II1.050.23–4.660.9545.150.91–29.090.064
 III3.901.35–11.220.0126.351.39–29.010.017
Subtype0.0020.111
 Luminal AReferenceReference
 Luminal B1.540.34–7.040.5792.200.31–20.460.456
 HER21.150.30–4.380.8402.180.30–15.460.436
 Triple-negative6.932.05–23.350.0026.551.15–32.140.024
ΔSUVmax*0.970.95–0.99<0.0010.970.95–0.990.015
  • * Continuous variable.

  • CI = confidence interval.